Literature DB >> 28084543

[Pregnancy and lactation-associated osteoporosis].

M Gehlen1, A D Lazarescu2, C Hinz3, B Boncu3, N Schmidt3, M Pfeifer3, M Schwarz-Eywill3, W Pollähne3, H W Minne3.   

Abstract

Pregnancy and lactation-associated osteoporosis (PLO) is a rare form of osteoporosis, which occurs in the last trimester or postpartum. So far 100 cases have been published. The leading symptoms are severe low back pain or less frequently hip pain. Many patients develop postpartum depression due to inability to care for the baby and vertebral fractures. The therapeutic decision has to be made individually but teriparatid and bisphosphonates seem to be the best option. We report the clinical course (16 years) of a 37-year-old patient with PLO, who suffered 6 vertebral fractures. There were severe physical limitations and mental problems caused by the disease. The patient was treated by multimodal therapy including physiotherapy and psychotherapy and bisphosphonates were given. The time between the onset of symptoms and diagnosis was 5 months. No further fractures occurred in the following 16 years. The physical and mental condition significantly improved.

Entities:  

Keywords:  Bisphosphonate; Depression; Pregnancy and lactation associated osteoporosis (PLO); Teriparatid; Vertebral fracture

Mesh:

Substances:

Year:  2017        PMID: 28084543     DOI: 10.1007/s00393-016-0259-z

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  9 in total

1.  Bisphosphonates in pregnancy and lactation-associated osteoporosis.

Authors:  S M O'Sullivan; A B Grey; R Singh; I R Reid
Journal:  Osteoporos Int       Date:  2006-04-27       Impact factor: 4.507

Review 2.  Presentation and management of osteoporosis presenting in association with pregnancy or lactation.

Authors:  C S Kovacs; S H Ralston
Journal:  Osteoporos Int       Date:  2015-05-05       Impact factor: 4.507

3.  Effect of teriparatide on pregnancy and lactation-associated osteoporosis with multiple vertebral fractures.

Authors:  Eun Yeong Choe; Je Eun Song; Kyeong Hye Park; Hannah Seok; Eun Jig Lee; Sung-Kil Lim; Yumie Rhee
Journal:  J Bone Miner Metab       Date:  2011-11-23       Impact factor: 2.626

4.  An ultra-brief screening scale for anxiety and depression: the PHQ-4.

Authors:  Kurt Kroenke; Robert L Spitzer; Janet B W Williams; Bernd Löwe
Journal:  Psychosomatics       Date:  2009 Nov-Dec       Impact factor: 2.386

5.  Pregnancy-associated osteoporosis: does the skeleton recover?

Authors:  A J Phillips; S J Ostlere; R Smith
Journal:  Osteoporos Int       Date:  2000       Impact factor: 4.507

6.  Postpartum depression co-occurring with lactation-related osteoporosis.

Authors:  Basak Ozcelik; Aykan Ozcelik; Mursel Debre
Journal:  Psychosomatics       Date:  2009 Mar-Apr       Impact factor: 2.386

Review 7.  Bone metabolic changes during pregnancy: a period of vulnerability to osteoporosis and fracture.

Authors:  Lucía Sanz-Salvador; Miguel Ángel García-Pérez; Juan J Tarín; Antonio Cano
Journal:  Eur J Endocrinol       Date:  2014-09-10       Impact factor: 6.664

8.  Osteoporosis with vertebral fractures associated with pregnancy: two case reports.

Authors:  Gloria Raffaetà; Maurizio Mazzantini; Agnese Menconi; Vanna Bottai; Francesca Falossi; Ilenia Celauro; Giulio Guido
Journal:  Clin Cases Miner Bone Metab       Date:  2014-05

9.  Effects of a new spinal orthosis on posture, trunk strength, and quality of life in women with postmenopausal osteoporosis: a randomized trial.

Authors:  Michael Pfeifer; Bettina Begerow; Helmut W Minne
Journal:  Am J Phys Med Rehabil       Date:  2004-03       Impact factor: 2.159

  9 in total
  2 in total

1.  Woman with Pregnancy and Lactation-Associated Osteoporosis (PLO).

Authors:  Nasrin Bazgir; Elham Shafiei; Neda Hashemi; Hassan Nourmohamadi
Journal:  Case Rep Obstet Gynecol       Date:  2020-11-12

2.  Barton Fracture of the Distal Radius in Pregnancy and Lactation-Associated Osteoporosis: A Case Report and Literature Review.

Authors:  Gang Wang; Xiaodong Bai
Journal:  Int J Gen Med       Date:  2020-11-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.